{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:30:48Z","timestamp":1781976648253,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.clcc.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:12:09Z","timestamp":1554509529000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Shu Y.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8399-6330","authenticated-orcid":false,"given":"Kathryn L.","family":"Colborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajhem","family":"Cambridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Reidy-Lagunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-4670","authenticated-orcid":false,"given":"Leonard B.","family":"Saltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Paty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-7984","authenticated-orcid":false,"given":"Martin R.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garcia-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-6355","authenticated-orcid":false,"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2019.04.001_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.6004\/jnccn.2014.0056","article-title":"Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer","volume":"12","author":"Cercek","year":"2014","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.clcc.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2005.04.4875","article-title":"Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer","volume":"24","author":"Chau","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fernandez-Martos","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib5","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/annonc\/mdr473","article-title":"Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study","volume":"23","author":"Marechal","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib6","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Rectal Cancer, v1.2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf. Accessed: May 14, 2019."},{"key":"10.1016\/j.clcc.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijrobp.2015.02.021","article-title":"Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting","volume":"92","author":"Gilbert","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2019.04.001_bib8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/cncr.24963","article-title":"Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer","volume":"116","author":"Chen","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2019.04.001_bib9","first-page":"119","article-title":"Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer","volume":"5","author":"Flores","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.clcc.2019.04.001_bib10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a Radiation Therapy Oncology Group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2019.04.001_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00005650-200110000-00009","article-title":"Symptom indexes to assess outcomes of treatment for early prostate cancer","volume":"39","author":"Clark","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.clcc.2019.04.001_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2019.04.001_bib14","series-title":"R\u00a0Core Team","year":"2015"},{"key":"10.1016\/j.clcc.2019.04.001_bib15","first-page":"362","article-title":"The emerging role of neoadjuvant chemotherapy for rectal cancer","volume":"5","author":"Boland","year":"2014","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00066-010-2194-2","article-title":"Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?","volume":"186","author":"Rodel","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clcc.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"Gerard","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04","volume":"32","author":"O\u2019Connell","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"4 Suppl","key":"10.1016\/j.clcc.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1200\/JCO.2017.35.4_suppl.662","article-title":"Total neoadjuvant therapy for locally advanced rectal cancer","volume":"35","author":"Cercek","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.04.001_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000258662","article-title":"Influence of gender and age on anorectal function: normal values from anorectal manometry in a large caucasian population","volume":"81","author":"Gundling","year":"2010","journal-title":"Digestion"},{"key":"10.1016\/j.clcc.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cger.2013.10.003","article-title":"Anorectal physiology and pathophysiology in the elderly","volume":"30","author":"Yu","year":"2014","journal-title":"Clin Geriatr Med"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300281830598X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300281830598X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:05:25Z","timestamp":1761519925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153300281830598X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S153300281830598X"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2019.04.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}